Cite
MLA Citation
A Cordero et al.. “LDLc reduction with fixed-dose combination rosuvastatin-ezetimibe in patients with coronary heart disease that are not candidates for PCSK9 inhibitors treatment.” European heart journal, vol. 42, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100144497120.0x000057